Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Inc (NY: ELAN )

16.74 -0.26 (-1.53%)
Streaming Delayed Price Updated: 3:17 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Inc

< Previous 1 2 3 4 5 6 7 8 Next >
US Stock Futures Slide On Inflation Fears: Analyst Sees Risk-Off Mood As Debt-Ceiling Crisis Looms
Via Benzinga
Elanco Animal Health Reports First Quarter 2023 Results
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus
From Elanco Animal Health Incorporated
Via Business Wire
Expert Ratings for Elanco Animal Health
Via Benzinga
Earnings Preview: Elanco Animal Health
Via Benzinga
What 4 Analyst Ratings Have To Say About Elanco Animal Health
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Animal Health's Return On Capital Employed Overview
Via Benzinga
Where Elanco Animal Health Stands With Analysts
Elanco Animal Health (NYSE:ELAN) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Expert Ratings for Elanco Animal Health
Within the last quarter, Elanco Animal Health (NYSE:ELAN) has observed the following analyst ratings: 
Via Benzinga
Elanco to Participate in the Barclays Global Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
Elanco to Participate in the Cowen 43rd Annual Health Care Conference
From Elanco Animal Health Incorporated
Via Business Wire
Elanco to Participate in the Bank of America 2023 Animal Health Summit
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Animal Health (ELAN) Q4 2022 Earnings Call Transcript
ELAN earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023. 
Via Benzinga
Elanco Animal Health Clocks 11% Lower Q4 Sales, FY22 Profit Guidance Below Consensus
Via Benzinga
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
From Elanco Animal Health Incorporated
Via Business Wire
Nasdaq, S&P 500 Futures Slump As Traders Weigh-In Retail Earnings, Uncertain Economic Backdrop
Trading in the index futures suggests stocks may open Monday’s session on a markedly negative note, although retail earnings scheduled for the day and a couple of readings on the manufacturing and the... 
Via Benzinga
Elanco Adds Animal Health Veteran to Executive Committee
From Elanco Animal Health Incorporated
Via Business Wire
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024. 
Via MarketBeat
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Elanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
From Elanco Animal Health Incorporated
Via Business Wire
Nasdaq, S&P 500 Futures Nervously Flit Around Ahead Of November Payrolls Data: Will Numbers Support Market Expectations For Slower Rate Hikes?
US stocks are on track for a nervous start on Friday as traders look ahead to the November non-farm payrolls report for trading cues. With the Federal Reserve signaling its intention to potentially... 
Via Benzinga
Elanco to Participate in Evercore ISI 5th Annual HealthCONx Conference
From Elanco Animal Health Incorporated
Via Business Wire
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at... 
Via Benzinga
What 6 Analyst Ratings Have To Say About Elanco Animal Health
Over the past 3 months, 6 analysts have published their opinion on Elanco Animal Health (NYSE:ELAN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.